Literature DB >> 19515283

Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Andres M Kanner1.   

Abstract

Depression is the most common psychiatric comorbidity in people with epilepsy, but it remains underrecognized and undertreated. In addition to its negative impact on quality of life, depressive disorders are predictive of a worse response to pharmacologic and surgical treatment of seizure disorders. This phenomenon is probably an expression of a bidirectional relationship between epilepsy and depression, which in turn is indicative of common pathogenic mechanisms that are operant in the two conditions. The abnormal role of the hypothalamic-pituitary-adrenal axis is one of the common pathogenic mechanisms that explains why patients with depression are at greater risk for developing epilepsy and vice versa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515283     DOI: 10.1007/s11910-009-0046-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  41 in total

1.  Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients.

Authors:  J Lehrner; R Kalchmayr; W Serles; A Olbrich; E Pataraia; S Aull; J Bacher; F Leutmezer; G Gröppel; L Deecke; C Baumgartner
Journal:  Seizure       Date:  1999-04       Impact factor: 3.184

2.  Patient-validated content of epilepsy-specific quality-of-life measurement.

Authors:  F Gilliam; R Kuzniecky; E Faught; L Black; G Carpenter; R Schrodt
Journal:  Epilepsia       Date:  1997-02       Impact factor: 5.864

3.  Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists.

Authors:  T Z Baram; W G Mitchell; K Brunson; E Haden
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

4.  Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path.

Authors:  Annalisa Scimemi; Stephanie Schorge; Dimitri M Kullmann; Matthew C Walker
Journal:  J Neurophysiol       Date:  2005-11-09       Impact factor: 2.714

5.  Psychiatric outcome after temporal lobectomy: a predictive study.

Authors:  S Anhoury; R J Brown; E S Krishnamoorthy; M R Trimble
Journal:  Epilepsia       Date:  2000-12       Impact factor: 5.864

Review 6.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

7.  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

8.  Psychiatric comorbidity in epilepsy: a population-based analysis.

Authors:  Jose F Tellez-Zenteno; Scott B Patten; Nathalie Jetté; Jeanne Williams; Samuel Wiebe
Journal:  Epilepsia       Date:  2007-07-28       Impact factor: 5.864

9.  Symptoms of depression and anxiety in pediatric epilepsy patients.

Authors:  A B Ettinger; D M Weisbrot; E E Nolan; K D Gadow; S A Vitale; M R Andriola; N J Lenn; G P Novak; B P Hermann
Journal:  Epilepsia       Date:  1998-06       Impact factor: 5.864

10.  The influence of comorbid depression on quality of life for people with epilepsy.

Authors:  Joyce A Cramer; David Blum; Michael Reed; Kristina Fanning
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

View more
  6 in total

1.  Neural Regulation of the Stress Response: The Many Faces of Feedback.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Cell Mol Neurobiol       Date:  2012-02-01       Impact factor: 5.046

2.  Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

Review 3.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

Review 4.  Rhythm and blues: animal models of epilepsy and depression comorbidity.

Authors:  S Alisha Epps; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

5.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights.

Authors:  Gaurav Kumar; Nigel C Jones; Margaret J Morris; Sandra Rees; Terence J O'Brien; Michael R Salzberg
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.